Johnson and Johnson Pvt. Ltd has been ordered to pay Rs 74.6 lakh to an unidentified Mumbai-based patient.
The order has been issued by India’s drug regulator Central Drugs Standard Control Organisation (CDSCO) in a major breakthrough for patients in the Johnson and Johnson Pvt. Ltd’s faulty hip implants case.
On 8 March, the government approved the recommendation of the central expert committee. It had examined and said the patient implanted with the “faulty” hip implant on both hips is entitled for financial compensation as per the government-approved formula.
The patient had also undergone a revision surgery in his left hip.
“As per the formula, the central expert committee has recommended for payment compensation of Rs 74,57,180 to the patient,” said the order.
On 29 November, the centre had approved the formula devised by a government experts panel, which determined the quantum of compensation so that patients could secure the compensation amount from the company.
The central expert committee under Dr R.K. Arya, director sports injury centre, Safdarjung Hospital, had examined the documents, including the disability certificates issued by the medical authority of Maharashtra, to decide on the compensation.
The decision was subsequently backed by the recommendation of a state (Maharashtra) level committee.